Authors
Yiu Ming Cheung, Hoi Wa Yeung, Chufeng He, Qile Zhang, Chui Yiu Bamboo Chook, Gary Tse, Yun Liao, Wing Tak Wong
Published in
Proceedings of the National Academy of Sciences of the United States of America. Volume 123. Issue 44. Pages e2609322123. Nov 03, 2026. Epub Oct 29, 2026.
Abstract
Programmed cell death ligand-1 (PD-L1) is an immune checkpoint protein expressed in vascular endothelial cells (ECs). In contrast to cancer, our understanding of endothelial PD-L1 in relation to metabolic syndromes and its vascular complications is less studied. For example, its regulation and intrinsic function remain unclear. Here, we showed that endothelial PD-L1 is regulated by leptin receptor signaling in male mice. In particular, endothelial PD-L1 expression is affected by leptin resistance. A lack of leptin receptors leads to PD-L1 downregulation in vascular ECs via posttranslational degradation. To understand the fundamental roles of endothelial PD-L1, RNA interference and selective knockout are employed in human endothelium and animals, respectively. Silencing or deleting endothelial PD-L1 expression delays cell cycle progression and proliferation due to rat sarcoma (RAS)/mitogen-activated protein kinase (MAPK) inactivation. In obesity, endothelial PD-L1 deficiency impairs the EC turnover and worsens the vascular function. Overall, we provide an insight into how endothelial PD-L1 contributes to vascular homeostasis, suggesting its pathophysiological importance in maintaining cellular turnover.
PMID:
42956031
Bibliographic data and abstract were imported from PubMed on 30 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0